In patients with malignant glioma, the CD4+T-cell count decreased dramatically in the peripheral blood, spleen, and cervical lymph nodes, while Tregs significantly accumulated in the tumor microenvironment; both collectively contributing to the immunosuppressive milieu of the tumor [25, 79]. The gene discussed is CD4; the disease is malignant glioma.